Dr. Peter C. Pelikan, MD

Dr. Pelikan practices at Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services.

Dr. Pelikan's NPI, 1710984331, was assigned on June 29, 2005. Dr. Pelikan graduated from Harvard Medical School in 1979. Dr. Pelikan holds California license G43904.

Dr. Pelikan's primary practice is Providence Saint John's Health Center, at 2121 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5511.

Dr. Pelikan's primary practice is Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services. Dr. Pelikan is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Pelikan to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pelikan practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Pelikan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Pelikan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Pelikan's licenses on file in 2 states: California and Maryland.

Dmand AI lists angioplasty, cardiac catheterization and endocarditis among the conditions Dr. Pelikan treats.

CMS data shows 2,566 Medicare services from Dr. Pelikan across 25 procedure codes in 2024, for 573 Medicare patients. Medicare paid $178,123 for them.

CMS counts 573 Medicare patients who saw Dr. Pelikan in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pelikan's median patient age at 77, with 38% women.

In 2024, Dr. Pelikan wrote 2,826 Medicare Part D claims for 394 patients. 85% of them were for generic drugs. CMS names the drug for 2,624 of them, across 40 drugs with 11 or more claims each, at $408,574 in total drug cost. In 2023, CMS named 2,862 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Pelikan for performance year 2024, reported as part of a group. Dr. Pelikan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pelikan as offering telehealth. CMS counts 42 procedures of coronary angioplasty and stenting by Dr. Pelikan, more than 78% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Pelikan. The most frequent topics are Dogs, Myocardium and Perfusion. Dr. Pelikan has published most often in Bull Fed Soc Gynecol Obstet Lang Fr. Dr. Pelikan's most frequent co-authors are James Niemann, MD, John M. Criley, MD and Ronald P. Karlsberg, MD.

CMS Open Payments shows 434 general payments to Dr. Pelikan from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Edwards Lifesciences Corporation paid the most, $8,354.

Dmand AI lists 6 awards for Dr. Pelikan, most recently Top Doctors:LA Area in 2013.

Dr. Pelikan graduated from Harvard Medical School in 1979. Dr. Pelikan is a member of ACC.

Dr. Pelikan is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.